SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-19-000038
Filing Date
2019-02-06
Accepted
2019-02-06 16:15:20
Documents
3
Period of Report
2019-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 29593
2 FORM OF SERIES A WARRANT, ISSUED TO INVESTORS ON JANUARY 31, 2019 exh4-1.htm EX-4.1 119036
3 FORM OF SERIES B WARRANT, ISSUED TO INVESTORS ON JANUARY 31, 2019 exh4-2.htm EX-4.2 98155
  Complete submission text file 0001136261-19-000038.txt   248113
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 19571737
SIC: 2834 Pharmaceutical Preparations